Hanmi Pharmaceutical Company Limited
Clinical trials sponsored by Hanmi Pharmaceutical Company Limited, explained in plain language.
-
New drug could reduce IV dependence for short bowel patients
Disease control Recruiting nowThis study tests an experimental drug called HM15912 (sonefpeglutide) in 18 adults with short bowel syndrome who need IV nutrition. The goal is to see if the drug is safe and can help the intestines absorb more nutrients, potentially reducing the need for IV support. Participants…
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 01, 2026 23:14 UTC
-
New obesity drug HM17321 enters first human safety tests
Symptom relief Recruiting nowThis early-stage study tests a single dose of the experimental drug HM17321 in 40 healthy adults with a body mass index between 20 and 27. The main goal is to check for side effects and how the drug moves through the body. Participants receive either the drug or a placebo and are…
Phase: PHASE1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC